US2012142651A1PendingUtilityA1

Method of treatment of allergic rhinitis

Assignee: BIGGADIKE KEITHPriority: Feb 4, 2002Filed: Feb 10, 2012Published: Jun 7, 2012

Est. expiryFeb 4, 2022(expired)· nominal 20-yr term from priority

Inventors:Keith Biggadike Ian Buxton Steven Coote Rosalyn Kay Nice Kenton Reed Amyn Sayani Avinash Chander Sharma

A61P 37/08A61P 5/44A61P 29/00A61K 9/0043A61K 31/58A61K 9/0078A61P 11/02A61K 47/38A61K 31/56A61K 45/06

PatentIndex Score

Cited by

References

Claims

Abstract

There is provided a method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof, wherein the administration is once-per-day and intranasal, and the total daily dose of the compound (I) is 50 to 100 μg.

Claims

exact text as granted — not AI-modified

1 . A method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) 
       
         
           
           
               
               
           
         
       
       or a solvate thereof, wherein the administration is once-per-day and intranasal, and the total daily dose of the compound (I) is 50 to 100 μg.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.